Aug 182021

Halberd Corporation’s VITA-SHIELD-MAX(TM) Available. Buy Now!

August 18th, 2021|Categories: Featured, Investor News, News|Tags: , , , , |

Jackson Center, PA, August 18, 2021 – Halberd Corporation’s (OTC-PINK: "HALB") Nutraceutical product, Vita-Shield-MaxTM is now available on  Vita-Shield-MaxTM is a specially formulated Nutraceutical to help maintain a healthy immune system. William A. Hartman, Halberd's Chairman, President & CEO, stated, “Halberd Corporation’s scientists put extensive research into the precise formulation of this neutraceutical product designed specifically to maintain a healthy immune system based on publications, including numerous medical articles and immune bio-scientific research.  As ...

Aug 162021

Halberd’s Disease Elimination Technology R&D at Youngstown State University (YSU) Draws Attention of CBS Affiliate WKBN

August 16th, 2021|Categories: Featured, Investor News, News|Tags: , , , , , , , , , , , |

Jackson Center, PA, August 16, 2021 – Halberd Corporation’s (OTC-PINK: "HALB") research at Youngstown State University (YSU) caught the attention of Youngstown, OH TV news station, WKBN, a CBS affiliate. The station’s 5:00PM newscast on Friday, August 13, 2021, included a segment on Halberd’s on-going research and testing of its groundbreaking, patent protected technology at YSU, which could revolutionize disease treatment worldwide as, reported by Dave Sess.  Watch the news segment and read the entire ...

Aug 92021

Halberd Corporation’s VITA-SHIELD-MAX(TM) Immunity Support Product Shipped

August 9th, 2021|Categories: Featured, Investor News, News|

Jackson Center, PA, August 9, 2021 – Halberd Corporation (OTC-PINK: "HALB") reports Vita-Shield-MaxTM, has been shipped!  With Covid-19 cases back on the rise fueled by the Delta Variant, this “Immunity Support Nutraceutical Product” is arriving at the right time. William A. Hartman, Halberd's Chairman, President & CEO, stated, “We will shortly begin selling Vita-Shield-MaxTM and will be releasing details on purchasing our product in the near future, once we have the product in inventory.” Halberd ...

Aug 12021

Halberd Corporation Adds Blood-Borne Disease Treatment Capability With Addition Of Noted Nephrologist

August 1st, 2021|Categories: Uncategorized|

Jackson Center, PA, August 11, 2021 – Halberd Corporation’s (OTC-PINK: "HALB") today confirmed the addition of Dr. Ned Kronfol as a member of its Scientific Advisory Board.  Dr. Kronfol is certified by the American Board of Internal Medicine and retired in 2019 as Adjunct Clinical Professor from the William Carey University College of Osteopathic Medicine.  Among many other notable accomplishments, Dr. Kronfol served as Medical Director- Renal Care Group/Fresenius Kidney Cat Lake Village, AR from ...

Jul 282021

Halberd Corporation Successfully Establishes Disease Eradication Proof-of-Concept – “Never Before Accomplished”

July 28th, 2021|Categories: Featured, Investor News, News|Tags: , , , , , , , , , , , , , , , , , |

A Major Step Towards the Elimination of Multiple Infectious Diseases and Possible Treatment for Alzheimer’s Disease/PTSD/CTE Jackson Center, PA, July 28, 2021 – Halberd Corporation (OTC-PINK: "HALB") establishes “proof of concept” taking a major step towards the elimination of multiple infectious diseases, such as, malaria, tuberculosis, sepsis, meningitis, and pandemics, among others, by successfully eliminating E. Coli bacteria through the use of its patent-pending laser emissive energy exposure technique.  Recently, at Youngstown State University (YSU) ...

Jul 222021

Halberd Corp. Advances the Elimination of Antigens Present in Alzheimer’s Disease & PTSD/Chronic Traumatic Encephalopathy

July 22nd, 2021|Categories: Featured, Investor News, News|Tags: , , , , , , , , , |

Jackson Center, PA, July 22, 2021 – Halberd Corporation (OTC-PINK: "HALB") confirms the shipment of samples of metallic nanoparticles conjugated to Alzheimer’s Disease (AD) antibodies, Tau and Phosphorylated Tau.  Having successfully conjugated the metallic nanoparticles (via its breakthrough patent-pending process), GreenBioAZ shipped the materials to Youngstown State University (YSU).  At YSU, Dr. William G. Sturrus, Chair of the Physics, Astronomy, Geology, and Earth Sciences Department and his team will immediately proceed to the next step ...

Go to Top